(1)
Ashoush, N. REVIEW ONPHARMACOKINETICS OF EMPAGLIFLOZIN, AN INHIBITOR OF THE SODIUM GLUCOSE CO-TRANSPORTER-2 (SGLT-2). Asian J Pharm Clin Res 2017, 10, 50-56.